HK Inno.N Corp banner
H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 56 900 KRW 5.57%
Market Cap: ₩1.6T

Gross Margin

45.7%
Current
Declining
by 0.2%
vs 3-y average of 45.9%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
45.7%
=
Gross Profit
₩460.4B
/
Revenue
₩1T

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
45.7%
=
Gross Profit
₩460.4B
/
Revenue
₩1T

Peer Comparison

Country Company Market Cap Gross
Margin
KR
HK Inno.N Corp
KOSDAQ:195940
1.6T KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
965.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
594B USD
Loading...
CH
Roche Holding AG
SIX:ROG
291.5B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
242.5B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
303.7B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
152.2B USD
Loading...
UK
GSK plc
XETRA:GS71
105.9B EUR
Loading...

Market Distribution

Higher than 82% of companies in Korea
Percentile
82st
Based on 2 511 companies
82st percentile
45.7%
Low
-646.5% — 12.8%
Typical Range
12.8% — 32.2%
High
32.2% — 54 001.3%
Distribution Statistics
Korea
Min -646.5%
30th Percentile 12.8%
Median 19.7%
70th Percentile 32.2%
Max 54 001.3%

HK Inno.N Corp
Glance View

Market Cap
1.6T KRW
Industry
Pharmaceuticals

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Intrinsic Value
57 689.66 KRW
Undervaluation 1%
Intrinsic Value
Price
H
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
45.7%
=
Gross Profit
₩460.4B
/
Revenue
₩1T
What is HK Inno.N Corp's current Gross Margin?

The current Gross Margin for HK Inno.N Corp is 45.7%, which is below its 3-year median of 45.9%.

How has Gross Margin changed over time?

Over the last 3 years, HK Inno.N Corp’s Gross Margin has increased from 41.5% to 45.7%. During this period, it reached a low of 41.3% on Dec 31, 2022 and a high of 48.5% on Dec 31, 2024.

Back to Top